scispace - formally typeset
K

Kai-yue Diao

Researcher at Sichuan University

Publications -  38
Citations -  463

Kai-yue Diao is an academic researcher from Sichuan University. The author has contributed to research in topics: Medicine & Ejection fraction. The author has an hindex of 9, co-authored 30 publications receiving 276 citations.

Papers
More filters
Journal ArticleDOI

Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis

TL;DR: The quantitative measurement of myocardial fibrosis via T1 mapping is associated with a favourable overall correlation with theMyocardial biopsy measurements, and further studies are required to determine the calibration of the T1 mapped results for the biopsy findings of different cardiomyopathies.
Journal ArticleDOI

Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion: a contrast-enhanced cardiovascular magnetic resonance study.

TL;DR: The results imply that a contrast-enhanced 3.0T CMR can detect subclinical myocardial dysfunction and impairedMyocardial microvascular perfusion in the early stages of T2DM, and that the myocardia dysfunction is associated with impaired coronary microv vascular perfusion.
Journal ArticleDOI

HRCT imaging features in representative imported cases of 2019 novel coronavirus pneumonia

TL;DR: Six cases confirmed with 2019-nCoV infection in West China Hospital were selected and their initial and follow-up HRCT features, along with the clinical characteristics, were investigated, finding a multifocal or unifocal involvement of ground-glass opacity (GGO), sometimes with consolidation and fibrosis.
Journal ArticleDOI

The Diagnostic Value of Global Longitudinal Strain (GLS) on Myocardial Infarction Size by Echocardiography: A Systematic Review and Meta-analysis.

TL;DR: The 2D STE results positively correlated with the infarction size quantified by CMR for patients who had experienced their first MI, suggesting this approach can serve as a good diagnostic index for assessinginfarction area.
Journal ArticleDOI

Protective role of beta-blockers in chemotherapy-induced cardiotoxicity-a systematic review and meta-analysis of carvedilol.

TL;DR: The prophylactic use of carvedilol exerted no impact on the early asymptomatic LVEF decrease but seemed to attenuate the frequency of clinically overt cardiotoxicity and prevent ventricular remodeling.